ImmuneBridge
Jesse Cotari has an extensive background in scientific research and academia. Jesse has experience working in diverse roles in biotech startups, research centers, and educational institutions. Jesse has been involved in various aspects of scientific research, from conducting independent projects to developing analytical platforms. Jesse's expertise ranges from cell therapy development to cellular analysis and disease screening. Jesse has a PhD in Immunology and Computational Biology from Joan & Sanford I. Weill Medical College of Cornell University and a B.S./B.S. in Management Science and Molecular Biology from UC San Diego.
This person is not in any teams
This person is not in any offices
ImmuneBridge
ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematologicalcancers. They will then attack solid tumors using the special benefits of their cellular source.